Atlas Trials

Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators.

Clinical trial NCT07289035 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07289035
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis - Complete
Start date
2026-01-15
Primary completion
2026-04-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.